Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations
- PMID: 37278449
- DOI: 10.1111/jgh.16250
Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations
Abstract
Background and aim: Some patients with functional gastrointestinal disorders exhibit pancreatic dysfunctions and pancreatic enzyme abnormalities. Thus, we aimed to clarify whether significant differences in clinical characteristics, prevalence of pancreatic enzyme abnormalities, duodenal inflammation, and protease-activated receptor 2 (PAR2) expression levels related to hypersensitivity exist between functional dyspepsia (FD) alone and FD-irritable bowel syndrome (IBS) overlap group.
Methods: Ninety-three patients based on the Rome IV criteria, FD alone (n = 44) and FD overlapped with IBS (n = 49) group were enrolled. The patients scored their own clinical symptoms after consuming high-fat meals. Serum trypsin, PLA2, lipase, p-amylase, and elastase-1 levels were measured. PAR2, eotaxin-3, and TRPV4 mRNA levels in duodenum were determined using real-time polymerase chain reaction methods. PRG2- and PAR2 in the duodenum were evaluated using immunostaining.
Results: FD score and global GSRS in patients with FD-IBS overlap were significantly higher than FD alone. Although the prevalence of pancreatic enzyme abnormalities in patients with FD alone was significantly (P < 0.01) higher than that in FD-IBS overlap, the ratio of aggravation of clinical symptoms following high-fat intake in patients with FD-IBS overlap was significantly higher (P = 0.007) than that in patients with FD alone. PAR2- and PRG2-double positive cells were localized in the degranulated eosinophils in the duodenum of patients with FD-IBS overlap. The number of PAR2- and PRG2-double positive cells in FD-IBS overlap was significantly (P < 0.01) higher than FD alone.
Conclusions: Pancreatic enzyme abnormalities and PAR2 expression on degranulated eosinophils infiltrations in the duodenum may be associated with the pathophysiology of patients with FD-IBS overlap in Asian populations.
Keywords: FD-IBS overlap; degranulated eosinophil; functional dyspepsia (FD); irritable bowel syndrome (IBS); protease activated receptor 2 (PAR2).
© 2023 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.PLoS One. 2022 Oct 20;17(10):e0275341. doi: 10.1371/journal.pone.0275341. eCollection 2022. PLoS One. 2022. PMID: 36264979 Free PMC article.
-
Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.J Nippon Med Sch. 2013;80(5):362-70. doi: 10.1272/jnms.80.362. J Nippon Med Sch. 2013. PMID: 24189354
-
The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.BMC Gastroenterol. 2008 Sep 23;8:43. doi: 10.1186/1471-230X-8-43. BMC Gastroenterol. 2008. PMID: 18808723 Free PMC article.
-
Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.Am J Gastroenterol. 2019 Mar;114(3):429-436. doi: 10.1038/s41395-018-0377-0. Am J Gastroenterol. 2019. PMID: 30839392
-
Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia.J Neurogastroenterol Motil. 2021 Apr 30;27(2):153-164. doi: 10.5056/jnm20175. J Neurogastroenterol Motil. 2021. PMID: 33795538 Free PMC article. Review.
Cited by
-
The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel syndrome.Sci Rep. 2024 Oct 21;14(1):24661. doi: 10.1038/s41598-024-74694-w. Sci Rep. 2024. PMID: 39433866 Free PMC article.
References
-
- Sahai AV, Mishra G, Penman ID et al. EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest. Endosc. 2000; 52: 153-159.
-
- Wakabayashi M, Futagami S, Yamawaki H et al. Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients. PLoS ONE 2018; 13: e0205165.
-
- Hashimoto S, Futagami S, Yamawaki H et al. Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography. J. Clin. Biochem. Nutr. 2017; 61: 140-145.
-
- Futagami S, Kessoku T, Kasai Y et al. Comparison of clinical characteristics, eating behaviors, and clinical symptoms following fat intake in functional dyspepsia with functional dyspepsia with pancreatic enzyme abnormalities between Singapore and Japan. J. Gastroenterol. Hepatol. 2022; 37: 1525-1533.
-
- Talley NJ, Holtmann G, Nguyen QN et al. Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain. J. Gastroenterol. Hepatol. 2017; 32: 1813-1817.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases